Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Change in Accured Expenses: 2013-2024

Historic Change in Accured Expenses for Soleno Therapeutics (SLNO) over the last 12 years, with Dec 2024 value amounting to $1.6 million.

  • Soleno Therapeutics' Change in Accured Expenses rose 528.57% to $968,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.7 million, marking a year-over-year increase of 423.05%. This contributed to the annual value of $1.6 million for FY2024, which is 12.40% up from last year.
  • Soleno Therapeutics' Change in Accured Expenses amounted to $1.6 million in FY2024, which was up 12.40% from $1.5 million recorded in FY2023.
  • Soleno Therapeutics' Change in Accured Expenses' 5-year high stood at $1.8 million during FY2020, with a 5-year trough of -$369,000 in FY2021.
  • Over the past 3 years, Soleno Therapeutics' median Change in Accured Expenses value was $1.5 million (recorded in 2023), while the average stood at $1.3 million.
  • Per our database at Business Quant, Soleno Therapeutics' Change in Accured Expenses crashed by 120.61% in 2021 and then surged by 356.64% in 2022.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Change in Accured Expenses stood at $1.8 million in 2020, then plummeted by 120.61% to -$369,000 in 2021, then soared by 356.64% to $947,000 in 2022, then surged by 54.17% to $1.5 million in 2023, then increased by 12.40% to $1.6 million in 2024.